Human Herpesvirus 8 Envelope-associated Glycoprotein B Interacts with Heparan Sulfate-like Moieties
Overview
Authors
Affiliations
Cell-surface heparan sulfate (HS) serves as an initial attachment receptor for several herpesviruses. The gamma2-human herpesvirus-8 (HHV-8) or Kaposi's sarcoma associated herpesvirus DNA and transcripts have been detected in B cells, endothelial cells, macrophages, and epithelial cells. HHV-8 infects a variety of human and animal cell lines leading to latent or abortive infection. Our studies showed that this broad cellular tropism may be in part due to HHV-8's interaction with the ubiquitous host cell-surface HS-like molecules. HHV-8 binding to the target cells and the infection were inhibited by soluble heparan, a glycosaminoglycan (GAG) closely related to HS. Since HHV-8 gB possess a putative heparan-binding domain (HBD) in the extracellular domain, the interaction of gB with HS-like moieties was examined. Unlike gB of gamma1-Epstein-Barr virus and gamma2-murine herpesvirus 68, HHV-8 gB was expressed on the surface of the infected cell membranes and virion envelopes. Envelope-associated gB was made up of 75 and 54 kDa polypeptides forming disulfide-linked heterodimers and multimers. Rabbit anti-gB antibodies neutralized HHV-8 infection. Virion envelope-associated gB specifically bound to heparan-agarose, which was eluted by high concentration of soluble heparan, but not by chondroitin sulfates. In vitro transcribed and translated products of gB gene specifically bound to heparan-agarose beads, which was blocked by HS and heparan, but not by other GAGs such as chondroitin sulfates (A, B, and C), N-acetyl heparan, and de-N-sulfated heparan. Biotinylated gB peptide corresponding to the putative HBD also bound to heparan. These results suggest that gB plays an important role in the infectious process of HHV-8 and virus interaction with cell-surface HS-like moieties could be in part mediated by the envelope-associated gB.
Estep R, Li H, Govindan A, McDonald K, Axthelm M, Wong S J Virol. 2025; 99(2):e0192324.
PMID: 39835812 PMC: 11852781. DOI: 10.1128/jvi.01923-24.
Liu S, Schlagowski S, Grosskopf A, Khizanishvili N, Yang X, Wong S PLoS Pathog. 2025; 21(1):e1012846.
PMID: 39820197 PMC: 11801733. DOI: 10.1371/journal.ppat.1012846.
Sucharita S, Krishnagopal A, van Drunen Littel-van den Hurk S Viruses. 2023; 15(10).
PMID: 37896835 PMC: 10611259. DOI: 10.3390/v15102058.
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine.
Casper C, Corey L, Cohen J, Damania B, Gershon A, Kaslow D NPJ Vaccines. 2022; 7(1):108.
PMID: 36127367 PMC: 9488886. DOI: 10.1038/s41541-022-00535-4.
Is heparan sulfate a target for inhibition of RNA virus infection?.
Ling J, Li J, Khan A, Lundkvist A, Li J Am J Physiol Cell Physiol. 2022; 322(4):C605-C613.
PMID: 35196165 PMC: 8977144. DOI: 10.1152/ajpcell.00028.2022.